If you thought grep was powerful, wait until you get a hold of ast-grep, which takes it to a whole new level.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

As investors place huge bets on its adoption, a string of issues remain unresolved inside the AI boom. ... Read More The post AI debates that will determine the future shape of markets appeared first ...

Theoretical ideas have a real-life impact,” said Michael Oser Rabin in a 2009 interview, 1 and he spent nearly seven decades ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...